Latest News

  • Follow the Money: Personalized Therapy for Colorectal Cancer, Methyl-Copying PCR Platform, More

    Diagnostics World News | Neogap Therapeutics advances their ongoing clinical study for personalized therapy for advanced colorectal cancer; Syndex Bio introduced its proprietary mcPCR (methyl-copying PCR) platform; and more.

    Feb 25, 2026

  • Precision Medicine Needs Precision Engineered Diagnostic Systems

    Diagnostics World News | Precision medicine is often described as the future of healthcare. But from an engineering standpoint, it’s already here, and it’s forcing diagnostic instruments to evolve faster than most development cycles are comfortable with. We’re asking instruments to do more than confirm a suspected diagnosis. We’re asking them to deliver specificity, speed, and confidence in environments that aren’t always predictable. That’s a major shift from the days when “good enough” screening could drive clinical decisions.

    Feb 20, 2026

  • Clock Model Predicts When Alzheimer’s Symptoms Will Appear

    Diagnostics World News | Researchers from the Foundation for the National Institutes of Health (FNIH), Washington University in St. Louis, the University of California San Francisco, the University of Wisconsin-Madison, and more have published results of a study using a single plasma biomarker sample to estimate not only the probability of an Alzheimer’s Disease diagnosis, but when symptoms will develop.

    Feb 19, 2026

  • Clock Model Predicts When Alzheimer’s Symptoms Will Appear

    Diagnostics World News | Researchers from the Foundation for the National Institutes of Health (FNIH), Washington University in St. Louis, the University of California San Francisco, the University of Wisconsin-Madison, and more have published results of a study using a single plasma biomarker sample to estimate not only the probability of an Alzheimer’s Disease diagnosis, but when symptoms will develop.

    Feb 19, 2026

  • PacBio’s Rare Disease, ASO Push

    Diagnostics World News | PacBio has announced several rare disease genomics programs so far this year. The most recent partner organizations include iHope, N-Lorem, EspeRare, UW Medicine, and Seattle Children’s Hospital.

    Feb 17, 2026

  • Zentropy: A New Framework to Transform Medical Prediction

    Diagnostics World News | A research team at Penn State is reshaping the future of diagnostics by embedding the laws of thermodynamics directly into artificial intelligence (AI). Their framework, called zentropy-embedded neural networks (ZENN) promises to improve how clinicians interpret complex, multi-source diagnostic data, from brain scans to blood tests.

    Feb 13, 2026

  • UK Consortium Builds Cancer Dataset and AI Models with 10x Xenium Spatial Platform

    Diagnostics World News | PharosAI, a research consortium of four UK institutions, plans to use the 10x Genomics Xenium spatial platform to build one of the world's most comprehensive multimodal cancer datasets and pair them with advanced AI models and analytical capabilities. They plan to democratize access to these datasets, ensuring they are securely available to a broad community of researchers and innovators.

    Feb 6, 2026

  • Parkinson’s Disease Can Now Be Identified in Blood

    Diagnostics World News | Soley Therapeutics will advance its proprietary cell stress sensing platform; Precede Biosciences’s platform aims to meet rapidly growing demand from developers of next-generation precision medicines; Proxima will accelerate the advancement of first-in-class proximity-modulating therapeutics; and more.

    Feb 5, 2026

  • Parkinson’s Disease Can Now Be Identified in Blood

    Diagnostics World News | No cure or established early-stage detection method for Parkinson's disease has been found yet. Patients do not receive a diagnosis until motor symptoms begin to appear. A team of researchers from Chalmers University of Technology, Sweden and Oslo University Hospital, Norway have found a way to identify early signs of Parkinson’s disease in the blood.

    Feb 5, 2026